ストックスクリーナーアプリを入手
15.79
13.84%
1.92
前日終値:
$13.87
開ける：
$13.73
24時間の取引高:
955.08K
Relative Volume:
2.22
時価総額：
$861.55M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+50.38%
1か月 パフォーマンス:
+32.24%
6か月 パフォーマンス:
+21.18%
1年 パフォーマンス:
-38.01%
1日の値動き範囲:
$13.59
$15.83
1週間の範囲:
$10.48
$15.83
52週間の値動き範囲:
$7.80
$28.09
Bicara Therapeutics Inc Stock (BCAX) Company Profile
名前
Bicara Therapeutics Inc
セクター
電話
617-468-4219
住所
116 HUNTINGTON AVENUE SUITE 703, BOSTON
BCAX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
15.79 | 756.79M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2025-05-23 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | 開始されました | Wells Fargo | Underweight |
| 2025-02-06 | 開始されました | Wedbush | Outperform |
| 2024-12-06 | 開始されました | H.C. Wainwright | Buy |
| 2024-11-05 | 開始されました | Rodman & Renshaw | Buy |
| 2024-10-08 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-10-08 | 開始されました | Morgan Stanley | Overweight |
| 2024-10-08 | 開始されました | Stifel | Buy |
| 2024-10-08 | 開始されました | TD Cowen | Buy |
すべてを表示
Bicara Therapeutics Inc (BCAX) 最新ニュース
Stifel maintains Buy on Bicara stock with $47 target - MSN
Key metrics from Bicara Therapeutics Inc.’s quarterly data2025 Key Lessons & AI Driven Price Predictions - newser.com
Bicara Therapeutics stock rating reiterated as Buy by TD Cowen - Investing.com India
Promising Market Opportunity for Bicara Therapeutics in HPV-Negative Head & Neck Cancer Warrants Buy Rating - TipRanks
What analysts say about Bicara Therapeutics Inc stockTrend Following Strategies & Big Profit Small Investment - earlytimes.in
Statistical indicators supporting Bicara Therapeutics Inc.’s strengthWeekly Investment Summary & High Conviction Buy Zone Alerts - newser.com
Brokerages Set Bicara Therapeutics Inc. (NASDAQ:BCAX) PT at $32.25 - Defense World
How to read the order book for Bicara Therapeutics Inc.Trade Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Can Bicara Therapeutics Inc. stock resist sector downturnsJuly 2025 Update & High Accuracy Trade Alerts - newser.com
Optimistic Buy Rating for Bicara Therapeutics: Superior Clinical Benefits and Valuation Upside - TipRanks
What drives Bicara Therapeutics Inc stock priceMACD Histogram Signals & Calculate Profit Targets With AI Accuracy - earlytimes.in
Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Bicara Therapeutics (NASDAQ:BCAX) Shares Up 7.8%Here's What Happened - MarketBeat
Atle Fund Management AB Acquires 27,547 Shares of Bicara Therapeutics Inc. $BCAX - MarketBeat
Analyzing recovery setups for Bicara Therapeutics Inc. investors2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
Is Bicara Therapeutics Inc. stock reversal real or fakeMarket Performance Recap & Weekly Stock Performance Updates - newser.com
Bicara Therapeutics (NASDAQ:BCAX) Trading Down 5.5%Time to Sell? - MarketBeat
Using flow based indicators on Bicara Therapeutics Inc.New Guidance & Intraday High Probability Alerts - newser.com
Revenue Check: Will Bicara Therapeutics Inc. benefit from current market trends2025 Major Catalysts & Reliable Price Action Trade Plans - خودرو بانک
Risks Report: What makes Q32 Bio Inc. stock attractive todayJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - khodrobank.com
What does recent volatility data suggest for Bicara Therapeutics Inc.Trade Ideas & Verified Entry Point Detection - newser.com
Is a relief rally coming for Bicara Therapeutics Inc. holdersJuly 2025 Analyst Calls & Technical Entry and Exit Alerts - newser.com
Is Bicara Therapeutics Incs growth already priced inMarket Sentiment Report & High Yield Stock Recommendations - خودرو بانک
What is Bicara Therapeutics Incs revenue forecastTrade Volume Report & Free Long-Term Investment Growth Plans - خودرو بانک
Volatility Watch: How cyclical is Bicara Therapeutics Incs revenue streamQuarterly Performance Summary & Entry and Exit Point Strategies - خودرو بانک
Rate Cut: What is Bicara Therapeutics Incs revenue forecastJuly 2025 Patterns & Long-Term Capital Growth Strategies - khodrobank.com
CEO Change: Is Bicara Therapeutics Inc.’s growth already priced inMarket Sentiment Summary & Weekly Top Gainers Alerts - khodrobank.com
Technical analysis overview for Bicara Therapeutics Inc. stock2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Is Atmus Filtration Technologies Inc stock a buy or sellJuly 2025 Big Picture & Entry Point Strategy Guides - khodrobank.com
Risk Off: What is Bicara Therapeutics Incs market position2025 Price Action Summary & Low Risk High Win Rate Picks - خودرو بانک
Levels Update: Will Digi Power X Inc outperform tech stocksGlobal Markets & Verified Momentum Stock Watchlist - khodrobank.com
Investment Review: What are analysts price targets for Bicara Therapeutics IncMarket Weekly Review & Free Long-Term Investment Growth Plans - خودرو بانک
Bicara Therapeutics Inc (BCAX) 財務データ
Bicara Therapeutics Inc (BCAX) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):